{"id":235331,"date":"2025-12-16T07:18:11","date_gmt":"2025-12-16T07:18:11","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/235331\/"},"modified":"2025-12-16T07:18:11","modified_gmt":"2025-12-16T07:18:11","slug":"singapore-cancer-testing-startup-sets-sights-on-us-expansion","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/235331\/","title":{"rendered":"Singapore cancer-testing startup sets sights on US expansion"},"content":{"rendered":"<p><a class=\"ArticleTag_articleTag__P1Zo7\" href=\"https:\/\/asia.nikkei.com\/business\/health-care\" data-trackable=\"primary-tag\" data-dark-mode=\"false\" rel=\"nofollow noopener\" target=\"_blank\">Health Care<\/a><\/p>\n<p class=\"NewsArticleHeader_newsArticleHeaderSubtitle__ZlvPp\" data-trackable=\"subhead\" data-dark-mode=\"false\">Lucence aims to double revenue with Medicare coverage and lab partnership<\/p>\n<p><img decoding=\"async\" class=\"image-main img-fluid ImageNew_imageNewImageResponsive__f1VTu\" src=\"https:\/\/www.europesays.com\/ie\/wp-content\/uploads\/2025\/12\/https:\/\/cms-image-bucket-productionv3-ap-northeast-1-a7d2.s3.ap-northeast-1.amazonaws.com\/images\/5\/9.jpeg\" alt=\"20251201 Lucence's laboratory\" width=\"780\" height=\"auto\" loading=\"eager\"\/><\/p>\n<p class=\"NewsArticleCaption_newsArticleCaption__fxo8v\" data-trackable=\"caption\" data-dark-mode=\"false\" style=\"display:block\">Blood samples are processed and analyzed at Lucence&#8217;s laboratory in Singapore. (Photo by Kentaro Takeda)<\/p>\n<p>KENTARO TAKEDA<\/p>\n<p>December 16, 2025 10:43 JST<\/p>\n<p data-dark-mode=\"false\" class=\"Paragraph_paragraph__2p1wC\">SINGAPORE &#8212; Lucence, a Singapore-based medical startup that offers cancer-testing services, is aiming to expand in the U.S. by leveraging coverage under the federal government&#8217;s Medicare insurance program and a recent partnership with a leading laboratory group.<\/p>\n","protected":false},"excerpt":{"rendered":"Health Care Lucence aims to double revenue with Medicare coverage and lab partnership Blood samples are processed and&hellip;\n","protected":false},"author":2,"featured_media":235332,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[275],"tags":[124922,18,38398,135,475,474,19,17,118248,124923,1999,934,107],"class_list":{"0":"post-235331","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-cancer-testing","9":"tag-eire","10":"tag-expansion","11":"tag-health","12":"tag-health-care","13":"tag-healthcare","14":"tag-ie","15":"tag-ireland","16":"tag-sets","17":"tag-sights","18":"tag-singapore","19":"tag-startup","20":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/115728030773987883","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/235331","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=235331"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/235331\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/235332"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=235331"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=235331"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=235331"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}